Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
I think the PR title of "PTSC Streamlines Subsidiary Operations" speaks enough, meaning it's not about the MMP Portfolio. Nothing in the PR suggests any changing status of the MMP past what we all already know from recent USPTO and PACER filings. That is, the MMP is still surrounded by uncertainty, with the '336 being in the best position to emerge from the uncertainty at this time.
